Taiho Oncology, Inc.
Overview
Taiho Oncology, Inc. is a subsidiary of Taiho Pharmaceutical Co., Ltd. The company specializes in the development of innovative cancer treatments and aims to address significant unmet medical needs in oncology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Taiho Oncology, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.